Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer

Yini Zhu(University of Notre Dame), Xin Lü(University of Notre Dame)

Science Immunology

March 10, 2023

10.1126/sciimmunol.ade4656

Cited by 29

Related Papers

Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1

|Cell Metabolism|2023|199

Ketogenic Diet Alters the Epigenetic and Immune Landscape of Prostate Cancer to Overcome Resistance to Immune Checkpoint Blockade Therapy

|Cancer Research|2024|56

UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells

|Scientific Reports|2020|27

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines

|Cells|2022|12

Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma

|BMC Cancer|2024|11